관절통 주사제 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global joint pain injections market size is expected to reach USD 16.68 Billion in 2034 from USD 6.80 Billion in 2025, growing at a CAGR of 10.49 during 2026-2034.This market is witnessing robust growth due to the increasing prevalence of arthritis, musculoskeletal disorders, and age-related joint conditions. Joint pain injections are widely used to manage pain, improve mobility, and enhance quality of life for patients suffering from chronic joint problems. Rising aging populations and growing awareness regarding non-surgical treatment options are supporting market expansion. Increased healthcare spending and improved access to orthopedic care are also contributing to demand.

Advancements in regenerative medicine and injectable therapies are transforming the treatment landscape. Healthcare providers are increasingly utilizing corticosteroid injections, hyaluronic acid therapies, and biologic treatments to address various joint conditions. Growing demand for minimally invasive procedures is encouraging wider adoption of injection-based treatments. Furthermore, ongoing clinical research aimed at improving treatment effectiveness is creating additional opportunities for market growth.

Future prospects remain highly favorable as healthcare systems focus on managing chronic musculoskeletal conditions more effectively. Innovations in regenerative therapies and personalized medicine approaches are expected to enhance treatment outcomes. Expanding healthcare infrastructure in emerging economies will further support market development. As the global burden of joint disorders continues to increase, demand for advanced joint pain injection therapies is expected to grow steadily.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type of Injection

• Steroid Joint Injection
• Hyaluronic Acid Injections
• Platelet-Rich Plasma (PRP) Injections
• Placental Tissue Matrix (PTM) Injections
• Other Types of Injections

By Joint Type

• Hip Joint
• Knee And Ankle
• Shoulder And Elbow
• Facet Joints Of The Spine
• Other Joint Types

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., AbbVie Inc., Bioventus LLC, Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Inc., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL JOINT PAIN INJECTIONS MARKET: BY TYPE OF INJECTION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type Of Injection
• 4.2. Steroid Joint Injection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hyaluronic Acid Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Platelet-Rich Plasma (PRP) Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Placental Tissue Matrix (PTM) Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Types of Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL JOINT PAIN INJECTIONS MARKET: BY JOINT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Joint Type
• 5.2. Hip Joint Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Knee And Ankle Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Shoulder And Elbow Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Facet Joints Of The Spine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Joint Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL JOINT PAIN INJECTIONS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL JOINT PAIN INJECTIONS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type Of Injection
  • 7.2.2 By Joint Type
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type Of Injection
  • 7.3.2 By Joint Type
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type Of Injection
  • 7.4.2 By Joint Type
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type Of Injection
  • 7.5.2 By Joint Type
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type Of Injection
  • 7.6.2 By Joint Type
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL JOINT PAIN INJECTIONS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Seikagaku Corporation
  • 9.2.2 Flexion Therapeutics Inc
  • 9.2.3 Zimmer Biomet Holdings Inc
  • 9.2.4 Sanofi S.A
  • 9.2.5 Anika Therapeutics Inc
  • 9.2.6 AbbVie Inc
  • 9.2.7 Bioventus LLC
  • 9.2.8 Eli Lilly And Company
  • 9.2.9 Ferring Pharmaceuticals Inc
  • 9.2.10 Pfizer Inc
  • 9.2.11 Teva Pharmaceutical Industries Limited
  • 9.2.12 Johnson & Johnson Services Inc
  • 9.2.13 Merck & Co. Inc
  • 9.2.14 GlaxoSmithKline Plc
  • 9.2.15 Novartis AG